Skip to content

Clinical Application of Artificial Oocyte Activation Technique (AOA) in ART

Clinical Application of Artificial Oocyte Activation Technique (AOA) in Assisted Reproduction Technology

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04519918
Enrollment
400
Registered
2020-08-20
Start date
2020-10-01
Completion date
2022-08-31
Last updated
2020-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertilization

Keywords

Fertilization failure, Artificial Oocyte Activation (AOA), Calcium ionophore, Fertilization

Brief summary

Oocyte activation is an imperative stage in the initiation of embryo development during the fertilization. Indeed, the entrance of sperm into the oocyte causes sequences of calcium oscillations in its cytoplasm, regulating a series of molecular events called oocyte activation. The intracytoplasmic sperm injection (ICSI) has allowed fertilization in couples with severe male factor infertility. But, there was still fertilization failure or low fertilization occurs in ICSI cycles. It has reported that insufficient of oocyte activation is the important cause of fertilization failure. Artificial oocyte activation (AOA) represents an effective technique, can restore the calcium oscillations to improve the fertilization. Here, the investigators explore the effective of different AOA methods including oocyte was injected CaCl2 or mechanical stimulated then treated with calcium ionophore.

Detailed description

The ICSI procedure improves fertilization rates in cases of male factor infertility. However, fertilization failure still occurs in 1-5% in ICSI cycles. The main cause of failed fertilization is failure to complete oocyte activation. Oocyte activation involves a multitude of molecular changes. The investigators use a variety of mechanical, electrical, and chemical methods to trigger the calcium oscillations necessary to activate oocytes. During mechanical activation of oocytes, oolemmas are pierced using a microneedle to trigger a calcium influx. Another method for mechanical oocyte activation is the direct microinjection of calcium into the oocyte to increase intracellular calcium. It has been described with the use of calcium ionophore A23187, which can mimic the natural pattern of calcium rise. Mechanical and chemical activation are the most commonly used methods for artificial oocyte activation, can mimic calcium oscillations resulting in successful fertilization. AOA, a highly specialized fertilization technique that can be added to conventional ICSI to overcome fertilization failure in patients that had failed fertilization or poor quality embryos history. When the number of retrieved oocytes was \>10, sibling oocytes were divided into 3 groups to perform the standard ICSI procedure (control group), chemical AOA (A1 experiment group) or mechanical AOA (A2 experiment group). When the number of retrieved oocytes was 6-10, sibling oocytes were randomized 1:1 to perform the chemical AOA (A1 experiment group) or mechanical AOA (A2 experiment group). The number of retrieved oocytes was 1-5, all oocytes were perform the chemical AOA. Control group, a single spermatozoon was injected into the ooplasm, standard ICSI procedure. A1 experiment group, were treated by injecting CaCl2 concurrently with ICSI followed by sequential exposure of calcium ionophore A23187 activation solution for two times of post-ICSI AOA. A2 experiment group, mechanical stimulation was done before standard ICSI procedure, then the oocytes were transferred into the calcium ionophore A23187 activation solution for two times of post-ICSI AOA. The investigators want to establish the effective and safe of different AOA methods, to improve the fertilization outcome and embryo quality, and finally obtain healthy offspring.

Interventions

BEHAVIORALAOA

AOA represents an invasive non-physiological technique.

Sponsors

Tang-Du Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
22 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* The patients suffered at least one complete fertilization failure or low fertilization rate after performing standard ICSI in previous cycle. Low fertilization was defined as less than 33% fertilization rate. * The patients suffered at least 2 cycles complete fertilization failure or low fertilization rate after performing IVF in previous cycle. Low fertilization was defined as less than 33% fertilization rate. * The sperm of the patients has the following characteristics: globozoospermia, acrosomal deletion or small, severe head deformity, etc. * Sperm of testicular origin and/or sperm that has been freeze-thawed. * The sperm was PLC-ζ missing. * The MII oocytes were IVM cultured and/or freeze-thawed. * The patients suffered at least 2 cycles no available embryos, because of the embryo development block or fragmentation.

Exclusion criteria

* Normal fertilization IVF/ICSI cycles.

Design outcomes

Primary

MeasureTime frameDescription
Efficacy of AOA on fertilization12 monthsAssess the normal fertilization rate (2PN rate)

Secondary

MeasureTime frameDescription
Efficacy of AOA on embryo quality12 monthsAssess the good-quality embryo rate
Efficacy of AOA on clinical outcome24 monthsAssess the live-birth rate

Countries

China

Contacts

Primary ContactWang Ming, Master
wangmingbio@snnu.edu.cn8613259809290

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026